NovaBay Pharmaceuticals

NVC-422 Gives NovaBay Huge Growth Potential
Seeking Alpha
Mon, 12/9/13 - 11:20 am
NVC-422
NovaBay Pharmaceuticals
adenoviral conjunctivitis
NovaBay: Topline Data From 2 Phase IIb Trials Presents Asymmetric Investment Opportunity
Seeking Alpha
Tue, 03/19/13 - 10:54 am
NovaBay Pharmaceuticals
auriclosene
Galderma
Novabay: A Novel Agent Against A Common Problem
Seeking Alpha
Wed, 02/20/13 - 11:55 am
NovaBay Pharmaceuticals
NVC-422
antibiotics
NovaBay's Sugar Daddy, Galderma, Pushes Impetigo Treatment
Seeking Alpha
Mon, 02/18/13 - 12:04 pm
Galderma
impetigo
NovaBay Pharmaceuticals
NVC-422
South Africa
How Big Pharma Gets Bigger, And What Little Pharma Can Do About It
Seeking Alpha
Wed, 02/6/13 - 10:12 am
Big Pharma
Novartis
NovaBay Pharmaceuticals
Sanofi
Roche
5 BioPharmas To Watch For Wednesday, September 5
Seeking Alpha
Wed, 09/5/12 - 12:46 pm
Amarin
GSK
BioSante
NovaBay Pharmaceuticals
Santarus
Sarepta
NovaBay Anti-Infective Programs Mitigate Risk
Seeking Alpha
Wed, 04/4/12 - 09:40 am
NovaBay Pharmaceuticals
anti-infectives
Aganocide
Biopharma Stocks To Watch This Week
Seeking Alpha
Thu, 01/19/12 - 11:12 am
BioDelivery Sciences
Biovest International
Celldex
MannKind
NovaBay Pharmaceuticals
Keryx
ImmunoCellular
Cel-Sci
Dendreon
Generex
Human Genome Sciences
NovaBay's Game-Changing Technology May Be Attracting Attention
Seeking Alpha
Wed, 12/14/11 - 10:58 am
NovaBay Pharmaceuticals
Aganocide
NVC-422
anti-infectives
NovaBay Pharmaceuticals: CEO Interview
TheStreet.com
Thu, 05/20/10 - 06:18 am
Pharma CEOs
NovaBay Pharmaceuticals
Alcon
Galderma
NovaBay Pharmaceuticals to Receive Increase in Funding and Support From Alcon
PR-Canada
Sun, 12/20/09 - 11:17 am
NovaBay Pharmaceuticals
Alcon